IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Does Green Tea Affect Postprandial Glucose, Insulin and Satiety in Healthy Subjects
This study has been completed.
Sponsor:
Skane University Hospital
Information provided by:
Skane University Hospital
ClinicalTrials.gov Identifier:
NCT01086189
First received: March 11, 2010
Last updated: NA
Last verified: December 2009
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Green tea consumption could lower the risk of type II diabetes, as suggested by epidemiological studies. There is also evidence from intervention studies that green tea can decrease blood glucose levels and contribute to weight loss.
The aim with this study is therefore to examine the postprandial effects of green tea on glycemic index, insulin levels and satiety in healthy individuals after the consumption of a meal.
| Condition |
|---|
| Diabetes Type 2 Obesity |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Crossover Time Perspective: Cross-Sectional |
Further study details as provided by Skane University Hospital:
Primary Outcome Measures:
- Postprandial glucose and insulin
Secondary Outcome Measures:
- Postprandial satiety
| Enrollment: | 14 |
| Study Start Date: | December 2009 |
| Study Completion Date: | February 2010 |
The study was conducted on 14 healthy volunteers, with a crossover design. Participants were randomized to either green tea or water. This was consumed together with a breakfast consisting of white bread. Blood samples were drawn at 0, 15, 30, 45, 60, 90 and 120 minutes. Participants completed two different satiety scores at the same time intervals.
Eligibility| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Study Population
14 healthy volunteers
Criteria
Inclusion Criteria:
- Healthy subjects
Exclusion Criteria:
- Diabetes
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01086189
Please refer to this study by its ClinicalTrials.gov identifier: NCT01086189
Locations
| Sweden | |
| Skane University Hospital | |
| Malmo, Skane, Sweden, 205 02 | |
Sponsors and Collaborators
Skane University Hospital
More Information
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| ClinicalTrials.gov Identifier: | NCT01086189 History of Changes |
| Other Study ID Numbers: |
2009/66 |
| Study First Received: | March 11, 2010 |
| Last Updated: | March 11, 2010 |
Additional relevant MeSH terms:
|
Diabetes Mellitus, Type 2 Diabetes Mellitus Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |
ClinicalTrials.gov processed this record on August 18, 2017